Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.JLL Partners completes acquisition of PharmaNet
The acquisition was completed on March 30, 2009 through the merger of JLL’s acquisition subsidiary, PDGI Acquisition (purchaser), with and into PharmaNet. As a result of the merger,
The acquisition was completed on March 30, 2009 through the merger of JLL’s acquisition subsidiary, PDGI Acquisition (purchaser), with and into PharmaNet. As a result of the merger,
The joint venture will develop and commercialize Novavax’s seasonal influenza virus-like-particle (VLP)-based vaccine candidate and Cadila’s therapeutic vaccine candidates against cancer as well as its adjuvants, biogeneric and
Atritech, a US-based medical device company, has completed a $30m round of financing. Thomas, McNerney & Partners led the round along with a substantial investment from Split Rock
Under the terms of the agreement, RiboTask will gain access to the worldwide sales and marketing team of Girindus, and Girindus through the collaboration with RiboTask will have
Dr Henney has been one of the leaders and founders of the US biotechnology industry since 1980. Dr Henney co-founded three publicly held US biotechnology companies: Immunex Corporation
This agreement brings together two innovative technologies: Seegene’s dual priming oligo (DPO) multiplex polymerase chain reaction technology and Randox’s biochip array technology. This combination facilitates highly sensitive and
According to the company, the CollaRx lidocaine sponge is a lyophilized collagen sponge containing purified type-I collagen protein and lidocaine, a locally acting anesthetic. The product is intended
Fred Middleton, chairman and acting CEO of Novocell, said: “This composition patent is a milestone achievement for Novocell and is the culmination of extensive research that opened the
Between 2005 and 2015, the committee is tasked with allocating approximately $100 million in order to encourage stem cell research in Connecticut. “The possibilities for health care therapies
Amicas will offer its image management solutions to the Australian marketplace through an exclusive distribution partnership with Healthinc. The Amicas solution suite will be tightly integrated with Healthinc’s